Biomoda Extends Pilot Trial on Lung Cancer Diagnostic

Cancer diagnostics company Biomoda announced … that it is extending the pilot clinical trial of its CyPath diagnostic assay for the detection of early-stage lung cancer to recruit additional participants for the positive control group, patients who have been diagnosed with lung cancer but have not yet begun treatment for the disease.
MarketWatch